United Arab Emirates

In line with our core view that emerging markets will drive industry growth, Qatar First Investment Bank (QFIB) and Dubai-based Ithmar Capital, a regional private equity firm, have... 2010-06-15

BMI View: Despite the shortcomings of low growth for the UAE pharmaceutical market in the long run, there are opportunities in the chronic disease field, in line with Middle Eastern... 2010-05-05

BMI View: Improving the regulatory pharmaceutical business environment will continue to attract foreign direct investment (FDI) into the UAE, despite its relatively lower levels of... 2010-05-04

BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underlines some of our key views for how the sector is performing in emerging markets.... 2010-04-20

UAE generic drugmaker Julphar has revealed plans to invest US$152.6mn in expanding its business into manufacturing facilities specifically for insulins. The move underlines several... 2010-04-19

The Health Authority in Abu-Dhabi has announced that the country should adopt more cost-effective drug procurement strategies, including the use of generic substitution. We believe... 2010-04-15

Sanofi Aventis has launched its cosmetic prescription drug, Sculptra, in the UAE following approval from the UAE Ministry of Health. The drug was also approved by the US FDA earlier... 2010-03-25